Back to top
more

Integer Holdings (ITGR)

(Delayed Data from NYSE)

$121.11 USD

121.11
166,267

+0.11 (0.09%)

Updated Jun 7, 2024 04:00 PM ET

After-Market: $121.11 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.08%
2Buy17.91%
3Hold9.44%
4Sell5.10%
5Strong Sell2.55%
S&P50011.04%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value C Growth B Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 36% (158 out of 248)

Industry: Medical - Instruments

Better trading starts here.

Zacks News

Why You Should Add Chemed (CHE) Stock to Your Portfolio Now

Within Chemed's (CHE) VITAS business, management notes the recent admission trends to be consistently positive and this momentum is likely to continue.

    Here's Why You Should Invest in Illumina (ILMN) Stock Now

    Illumina (ILMN) gains on strategic partnerships and international prospects.

      Ecolab's New Aquanomic Enhances Laundry Operations at Hotels

      Ecolab's (ECL) new Aquanomic 2.0 Low-Temp Solid Laundry Program likely to boost Global Institutional segment.

        Cerner (CERN) Strong on EHR Prospects, Competition Intense

        Cerner's (CERN) strong EHR prospects and global outlook aid the company; margins continue to decline.

          Neogen's (NEOG) Listeria Right Now Gets Approval from AOAC

          Neogen's (NEOG) Listeria Right Now likely to prove beneficial in preventing food-borne diseases in the United States.

            DaVita Healthcare Partners' New Facility Now in Los Angeles

            DaVita's (DVA) incessant efforts to upgrade services, global expansion initiatives and active acquisitions are impressive.

              Here's Why You Should Hold AmerisourceBergen (ABC) Stock Now

              Strong performance in the World Courier Business is likely to provide AmerisourceBergen (ABC) a competitive edge in the MedTech space.

                Masimo (MASI) Scales a 52-Week High: What's Driving It?

                Masimo's (MASI) solid guidance for 2018 and a broad product spectrum drive stock.

                  Myriad Genetics (MYGN) Beats on Earnings & Revenues in Q4

                  Myriad Genetics (MYGN) witnesses strong performances from GeneSight, EndoPredict, Vectra DA and Prolaris tests in Q4.

                    Avanos Medical (AVNS) Jumps: Stock Rises 5.5%

                    Avanos Medical (AVNS) saw a big move last session, as its shares jumped more than 5% on the day, amid huge volumes.

                      Medtronic (MDT) Q1 Earnings Beat on Growth in All Lines

                      All major business groups of Medtronic (MDT) contribute to solid top-line growth at CER, which highlighted sustainability across groups and regions.

                        Is Integer Holdings (ITGR) Stock Outpacing Its Medical Peers This Year?

                        Is (ITGR) Outperforming Other Medical Stocks This Year?

                          Here's Why You Should Add Amedisys (AMED) to Your Portfolio

                          Amedisys (AMED) witnesses solid Medicare and non-Medicare revenues at Home Health and Hospice divisions. A favorable demographic trend bodes well.

                            Becton, Dickinson Hits at a 52-Week High: What's Driving It?

                            Becton, Dickinson (BDX) gains on solid fiscal Q3 results; view impressive.

                              Accuray (ARAY) Earnings Beat in Q4, Gross Orders Rise Y/Y

                              Accuray's (ARAY) flagship Radixact System drives Q4 results; overseas gains raise hope.

                                Intuitive Surgical Gains From Solid Q2 and Strong AI Exposure

                                Intuitive Surgical's (ISRG) impressive second-quarter 2018, strength in robotics and AI trends buoy optimism.

                                  CVS Health's PBM Selling Season Strong, Aetna Deal on Track

                                  A solid 2019 PBM selling season is a significant positive for CVS Health's (CVS) growth. The company completes more than 70% of its client renewals, almost in line with the prior-year level.

                                    Amedisys (AMED) Grows on Robust Home Health, Personal Care

                                    Amedisys' (AMED) solid performance in Personal Care division is impressive. Plus, a favorable demographic trend and calculating buyouts bode well for the company.

                                      ITGR or LMNX: Which Is the Better Value Stock Right Now?

                                      ITGR vs. LMNX: Which Stock Is the Better Value Option?

                                        Integra LifeSciences Codman Arm Strong, Competition Rife

                                        Integra LifeSciences' (IART) progress within its channel expansion strategy and Codman integration buoys investors' optimism on the stock.

                                          Inogen's Solid Europe Business Shapes Q2, Prospects Bright

                                          Inogen's (INGN) Europe performance solid in Q2; guidance for 2018 encourages.

                                            Surmodics' (SRDX) IVD Unit Boosts Growth, R&D Focus Solid

                                            Surmodics' (SRDX) strong focus on R&D to provide it a competitive edge in the MedTech space.

                                              Boston Scientific to Expand Within PI Via VENITI Buyout

                                              Presence of venous obstructive disease visibly grows across the globe, indicating huge prospects for Boston Scientific (BSX) in the treatment market.

                                                Here's Why You Should Dump DENTSPLY (XRAY) Stock Right Now

                                                DENTSPLY (XRAY) incurs goodwill and intangible impairment charge. A lowered guidance is a concern.

                                                  Zacks.com highlights: Turtle Beach, Integer Holdings and PCM

                                                  Zacks.com highlights: Turtle Beach, Integer Holdings and PCM